Quest Diagnostics Incorporated (0KSX.L)
USD 163.73
(-0.76%)
USD 163.73
(-0.76%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 854 Million USD | -9.73% |
| 2022 | 946 Million USD | -52.58% |
| 2021 | 1.99 Billion USD | 39.41% |
| 2020 | 1.43 Billion USD | 66.78% |
| 2019 | 858 Million USD | 16.58% |
| 2018 | 736 Million USD | -4.66% |
| 2017 | 772 Million USD | 19.69% |
| 2016 | 645 Million USD | -9.03% |
| 2015 | 709 Million USD | 27.52% |
| 2014 | 556 Million USD | -34.51% |
| 2013 | 849 Million USD | 52.78% |
| 2012 | 555.7 Million USD | 18.08% |
| 2011 | 470.6 Million USD | -34.72% |
| 2010 | 720.9 Million USD | -1.12% |
| 2009 | 729.1 Million USD | 25.38% |
| 2008 | 581.5 Million USD | 71.06% |
| 2007 | 339.93 Million USD | -42.03% |
| 2006 | 586.42 Million USD | 7.35% |
| 2005 | 546.27 Million USD | 9.43% |
| 2004 | 499.19 Million USD | 14.31% |
| 2003 | 436.71 Million USD | 35.56% |
| 2002 | 322.15 Million USD | 98.49% |
| 2001 | 162.3 Million USD | 59.04% |
| 2000 | 102.05 Million USD | 3101.53% |
| 1999 | -3.4 Million USD | -112.64% |
| 1998 | 26.9 Million USD | 220.63% |
| 1997 | -22.3 Million USD | 96.44% |
| 1996 | -625.96 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 194 Million USD | 1.04% |
| 2024 Q3 | 226 Million USD | -1.31% |
| 2024 Q2 | 229 Million USD | 18.04% |
| 2023 Q4 | 192 Million USD | -14.67% |
| 2023 Q1 | 202 Million USD | 100.0% |
| 2023 FY | 854 Million USD | -9.73% |
| 2023 Q2 | 235 Million USD | 16.34% |
| 2023 Q3 | 225 Million USD | -4.26% |
| 2022 FY | 946 Million USD | -52.58% |
| 2022 Q1 | 354 Million USD | -9.0% |
| 2022 Q2 | 233 Million USD | -34.18% |
| 2022 Q3 | 254 Million USD | 9.01% |
| 2022 Q4 | 101 Million USD | -60.24% |
| 2021 Q4 | 389 Million USD | -22.66% |
| 2021 FY | 1.99 Billion USD | 39.41% |
| 2021 Q1 | 468 Million USD | -18.75% |
| 2021 Q2 | 628 Million USD | 34.19% |
| 2021 Q3 | 503 Million USD | -19.9% |
| 2020 Q2 | 184 Million USD | 85.86% |
| 2020 Q3 | 566 Million USD | 207.61% |
| 2020 Q4 | 576 Million USD | 1.77% |
| 2020 Q1 | 99 Million USD | -60.87% |
| 2020 FY | 1.43 Billion USD | 66.78% |
| 2019 Q1 | 163 Million USD | 29.37% |
| 2019 Q4 | 253 Million USD | 18.22% |
| 2019 FY | 858 Million USD | 16.58% |
| 2019 Q2 | 206 Million USD | 26.38% |
| 2019 Q3 | 214 Million USD | 3.88% |
| 2018 Q2 | 219 Million USD | 24.43% |
| 2018 Q3 | 212 Million USD | -3.2% |
| 2018 FY | 736 Million USD | -4.66% |
| 2018 Q1 | 176 Million USD | -30.43% |
| 2018 Q4 | 126 Million USD | -40.57% |
| 2017 Q1 | 163 Million USD | 5.16% |
| 2017 Q4 | 253 Million USD | 58.13% |
| 2017 Q3 | 160 Million USD | -17.1% |
| 2017 FY | 772 Million USD | 19.69% |
| 2017 Q2 | 193 Million USD | 18.4% |
| 2016 FY | 645 Million USD | -9.03% |
| 2016 Q3 | 190 Million USD | -2.06% |
| 2016 Q2 | 194 Million USD | 88.35% |
| 2016 Q1 | 103 Million USD | -45.21% |
| 2016 Q4 | 155 Million USD | -18.42% |
| 2015 FY | 709 Million USD | 27.52% |
| 2015 Q4 | 188 Million USD | -44.71% |
| 2015 Q3 | 340 Million USD | 190.6% |
| 2015 Q2 | 117 Million USD | 91.8% |
| 2015 Q1 | 61 Million USD | -67.89% |
| 2014 FY | 556 Million USD | -34.51% |
| 2014 Q2 | 133 Million USD | 29.13% |
| 2014 Q1 | 103 Million USD | -27.48% |
| 2014 Q3 | 128 Million USD | -3.76% |
| 2014 Q4 | 190 Million USD | 48.44% |
| 2013 FY | 849 Million USD | 52.78% |
| 2013 Q4 | 142.02 Million USD | -64.85% |
| 2013 Q3 | 404 Million USD | 144.85% |
| 2013 Q2 | 165 Million USD | 22.22% |
| 2013 Q1 | 135 Million USD | 141.87% |
| 2012 Q3 | 162.43 Million USD | -8.22% |
| 2012 Q4 | 55.81 Million USD | -65.64% |
| 2012 Q2 | 176.99 Million USD | 11.65% |
| 2012 Q1 | 158.52 Million USD | -16.32% |
| 2012 FY | 555.7 Million USD | 18.08% |
| 2011 Q2 | 163.14 Million USD | 15.87% |
| 2011 Q4 | 189.43 Million USD | 10.24% |
| 2011 Q3 | 171.84 Million USD | 5.34% |
| 2011 FY | 470.6 Million USD | -34.72% |
| 2011 Q1 | 140.8 Million USD | -15.06% |
| 2010 Q1 | 162.44 Million USD | -10.54% |
| 2010 FY | 720.9 Million USD | -1.12% |
| 2010 Q2 | 194.61 Million USD | 19.8% |
| 2010 Q3 | 198.07 Million USD | 1.78% |
| 2010 Q4 | 165.75 Million USD | -16.32% |
| 2009 FY | 729.1 Million USD | 25.38% |
| 2009 Q1 | 167.1 Million USD | -1.6% |
| 2009 Q4 | 181.59 Million USD | -5.53% |
| 2009 Q3 | 192.21 Million USD | 2.14% |
| 2009 Q2 | 188.2 Million USD | 12.63% |
| 2008 Q4 | 169.81 Million USD | 53.34% |
| 2008 Q3 | 110.74 Million USD | -31.36% |
| 2008 FY | 581.5 Million USD | 71.06% |
| 2008 Q1 | 139.6 Million USD | 2758.67% |
| 2008 Q2 | 161.32 Million USD | 15.56% |
| 2007 Q1 | 105.89 Million USD | -29.07% |
| 2007 Q4 | -5.25 Million USD | -105.36% |
| 2007 Q3 | 97.96 Million USD | -30.68% |
| 2007 Q2 | 141.33 Million USD | 33.47% |
| 2007 FY | 339.93 Million USD | -42.03% |
| 2006 FY | 586.42 Million USD | 7.35% |
| 2006 Q4 | 149.28 Million USD | -7.0% |
| 2006 Q3 | 160.52 Million USD | 21.63% |
| 2006 Q2 | 131.97 Million USD | -8.75% |
| 2006 Q1 | 144.63 Million USD | 10.98% |
| 2005 Q2 | 149.08 Million USD | 13.28% |
| 2005 Q1 | 131.61 Million USD | 4.39% |
| 2005 Q4 | 130.32 Million USD | -3.64% |
| 2005 Q3 | 135.24 Million USD | -9.28% |
| 2005 FY | 546.27 Million USD | 9.43% |
| 2004 Q2 | 126.82 Million USD | 9.2% |
| 2004 FY | 499.19 Million USD | 14.31% |
| 2004 Q3 | 130.14 Million USD | 2.61% |
| 2004 Q1 | 116.14 Million USD | 7.3% |
| 2004 Q4 | 126.07 Million USD | -3.13% |
| 2003 Q3 | 120.02 Million USD | -0.32% |
| 2003 Q4 | 108.24 Million USD | -9.81% |
| 2003 Q2 | 120.41 Million USD | 36.78% |
| 2003 FY | 436.71 Million USD | 35.56% |
| 2003 Q1 | 88.03 Million USD | 7.76% |
| 2002 Q3 | 86.61 Million USD | -0.61% |
| 2002 FY | 322.15 Million USD | 98.49% |
| 2002 Q1 | 66.68 Million USD | 30.92% |
| 2002 Q2 | 87.15 Million USD | 30.68% |
| 2002 Q4 | 81.69 Million USD | -5.68% |
| 2001 Q3 | 50.12 Million USD | 96.6% |
| 2001 Q4 | 50.93 Million USD | 1.63% |
| 2001 FY | 162.3 Million USD | 59.04% |
| 2001 Q1 | 35.74 Million USD | 40.95% |
| 2001 Q2 | 25.49 Million USD | -28.68% |
| 2000 Q2 | 30.16 Million USD | 69.4% |
| 2000 Q3 | 28.71 Million USD | -4.83% |
| 2000 Q1 | 17.8 Million USD | 222.82% |
| 2000 FY | 102.05 Million USD | 3101.53% |
| 2000 Q4 | 25.36 Million USD | -11.66% |
| 1999 Q3 | -9.4 Million USD | -171.76% |
| 1999 Q1 | 7.43 Million USD | 37.65% |
| 1999 Q2 | 13.1 Million USD | 76.24% |
| 1999 FY | -3.4 Million USD | -112.64% |
| 1999 Q4 | -14.5 Million USD | -54.26% |
| 1998 Q4 | 5.4 Million USD | -11.48% |
| 1998 Q1 | 6.6 Million USD | 117.65% |
| 1998 Q2 | 8.9 Million USD | 34.85% |
| 1998 Q3 | 6.1 Million USD | -31.46% |
| 1998 FY | 26.9 Million USD | 220.63% |
| 1997 Q4 | -37.4 Million USD | -1346.67% |
| 1997 Q1 | 4 Million USD | 100.86% |
| 1997 Q2 | 8.1 Million USD | 102.5% |
| 1997 Q3 | 3 Million USD | -62.96% |
| 1997 FY | -22.3 Million USD | 96.44% |
| 1996 Q4 | -467.1 Million USD | -291.21% |
| 1996 Q3 | -119.4 Million USD | 0.0% |
| 1996 FY | -625.96 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Phreesia, Inc. | -136.88 Million USD | 723.881% |
| Accuray Incorporated | -15.54 Million USD | 5593.728% |
| Align Technology, Inc. | 445.05 Million USD | -91.887% |
| Elevance Health Inc. | 5.98 Billion USD | 85.736% |
| AxoGen, Inc. | -21.71 Million USD | 4032.584% |
| Boston Scientific Corporation | 1.59 Billion USD | 46.39% |
| CVS Health Corporation | 8.34 Billion USD | 89.765% |
| Cardinal Health, Inc. | 852 Million USD | -0.235% |
| Centene Corporation | 2.7 Billion USD | 68.394% |
| DaVita Inc. | 691.53 Million USD | -23.493% |
| HCA Healthcare, Inc. | 5.24 Billion USD | 83.709% |
| Hologic, Inc. | 789.5 Million USD | -8.17% |
| Humana Inc. | 2.48 Billion USD | 65.689% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | -1.06% |
| Laboratory Corporation of America Holdings | 418 Million USD | -104.306% |
| Masimo Corporation | 81.5 Million USD | -947.853% |
| McKesson Corporation | 3 Billion USD | 71.552% |
| Patterson Companies, Inc. | 185.93 Million USD | -359.31% |
| ResMed Inc. | 1.02 Billion USD | 16.352% |
| Henry Schein, Inc. | 416 Million USD | -105.288% |
| Teladoc Health, Inc. | -220.36 Million USD | 487.534% |
| Universal Health Services, Inc. | 717.79 Million USD | -18.975% |
| Veeva Systems Inc. | 525.7 Million USD | -62.449% |
| Baxter International Inc. | 2.65 Billion USD | 67.846% |
| Becton, Dickinson and Company | 1.48 Billion USD | 42.453% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 52.503% |
| Danaher Corporation | 4.2 Billion USD | 79.667% |
| Stryker Corporation | 3.16 Billion USD | 73.017% |
| Medtronic plc | 3.67 Billion USD | 76.768% |